( 0 1 0 1 O
either 1 7 1 7 O
the 8 11 8 11 O
influenza 12 21 12 21 B-chronic_disease
virus 22 27 22 27 I-chronic_disease
, 27 28 27 28 O
pneumococcal 29 41 29 41 B-treatment
or 42 44 42 44 O
meningococcal 45 58 45 58 B-treatment
vaccine 59 66 59 66 I-treatment
) 66 67 66 67 O

( 0 1 68 69 O
mild 1 5 69 73 O
illness 6 13 74 81 O
, 13 14 81 82 O
such 15 19 83 87 O
as 20 22 88 90 O
diarrhea 23 31 91 99 B-chronic_disease
or 32 34 100 102 O
mild 35 39 103 107 B-chronic_disease
respiratory 40 51 108 119 I-chronic_disease
infection 52 61 120 129 I-chronic_disease
with 62 66 130 134 O
or 67 69 135 137 O
without 70 77 138 145 O
fever 78 83 146 151 O
, 83 84 151 152 O
and 85 88 153 156 O
local 89 94 157 162 O
infections 95 105 163 173 O
do 106 108 174 176 O
not 109 112 177 180 O
apply 113 118 181 186 O
) 118 119 186 187 O

18 0 2 188 190 B-lower_bound
- 2 3 190 191 O
80 3 5 191 193 B-upper_bound
years 6 11 194 199 I-upper_bound
of 12 14 200 202 O
age 15 18 203 206 B-age

Any 0 3 207 210 O
clinically 4 14 211 221 O
significant 15 26 222 233 O
abnormality 27 38 234 245 O
on 39 41 246 248 O
medical 42 49 249 256 O
history 50 57 257 264 O
or 58 60 265 267 O
physical 61 69 268 276 O
examination 70 81 277 288 O
including 82 91 289 298 O
history 92 99 299 306 O
of 100 102 307 309 O
immunodeficiency 103 119 310 326 B-chronic_disease
or 120 122 327 329 O
autoimmune 123 133 330 340 B-chronic_disease
disease 134 141 341 348 I-chronic_disease

Any 0 3 349 352 O
clinically 4 14 353 363 O
significant 15 26 364 375 O
acute 27 32 376 381 O
or 33 35 382 384 O
chronic 36 43 385 392 O
medical 44 51 393 400 O
condition 52 61 401 410 O
requiring 62 71 411 420 O
care 72 76 421 425 O
of 77 79 426 428 O
a 80 81 429 430 O
physician 82 91 431 440 O
( 92 93 441 442 O
e.g. 93 97 442 446 O
, 97 98 446 447 O
diabetes 99 107 448 456 B-chronic_disease
, 107 108 456 457 O
coronary 109 117 458 466 B-chronic_disease
artery 118 124 467 473 I-chronic_disease
disease 125 132 474 481 I-chronic_disease
, 132 133 481 482 O
rheumatologic 134 147 483 496 B-chronic_disease
illness 148 155 497 504 I-chronic_disease
, 155 156 504 505 O
malignancy 157 167 506 516 B-cancer
, 167 168 516 517 O
substance 169 178 518 527 O
abuse 179 184 528 533 O
) 184 185 533 534 O
that 186 190 535 539 O
, 190 191 539 540 O
in 192 194 541 543 O
the 195 198 544 547 O
opinion 199 206 548 555 O
of 207 209 556 558 O
the 210 213 559 562 O
investigator 214 226 563 575 O
, 226 227 575 576 O
would 228 233 577 582 O
preclude 234 242 583 591 O
participation 243 256 592 605 O

Confirmed 0 9 606 615 O
HIV 10 13 616 619 B-chronic_disease
infection 14 23 620 629 I-chronic_disease
, 23 24 629 630 O
positive 25 33 631 639 O
for 34 37 640 643 O
hepatitis 38 47 644 653 B-chronic_disease
B 48 49 654 655 I-chronic_disease
surface 50 57 656 663 I-chronic_disease
antigen 58 65 664 671 I-chronic_disease
or 66 68 672 674 O
positive 69 77 675 683 O
for 78 81 684 687 O
hepatitis 82 91 688 697 B-chronic_disease
C 92 93 698 699 I-chronic_disease
antibodies 94 104 700 710 I-chronic_disease

Currently 0 9 711 720 O
taking 10 16 721 727 O
systemic 17 25 728 736 B-treatment
steroids 26 34 737 745 I-treatment
or 35 37 746 748 O
other 38 43 749 754 O
immunomodulatory 44 60 755 771 B-treatment
medications 61 72 772 783 I-treatment
including 73 82 784 793 O
anticancer 83 93 794 804 B-treatment
medications 94 105 805 816 I-treatment
and 106 109 817 820 O
antiviral 110 119 821 830 B-treatment
medications 120 131 831 842 I-treatment

Documented 0 10 843 853 O
previous 11 19 854 862 O
infection 20 29 863 872 O
with 30 34 873 877 O
dengue 35 41 878 884 B-chronic_disease
, 41 42 884 885 O
zika 43 47 886 890 B-chronic_disease
or 48 50 891 893 O
chikungunya 51 62 894 905 B-chronic_disease
virus 63 68 906 911 I-chronic_disease
or 69 71 912 914 O
no 72 74 915 917 O
history 75 82 918 925 O
of 83 85 926 928 O
dengue 86 92 929 935 O
, 92 93 935 936 O
zika 94 98 937 941 O
or 99 101 942 944 O
chikungunya 102 113 945 956 B-chronic_disease
infection 114 123 957 966 I-chronic_disease

Egg 0 3 967 970 B-allergy_name
allergy 4 11 971 978 O

Female 0 6 979 985 B-gender

For 0 3 986 989 O
Flumist 4 11 990 997 B-treatment
participants 12 24 998 1010 O
: 24 25 1010 1011 O
Close 26 31 1012 1017 O
contact 32 39 1018 1025 O
with 40 44 1026 1030 O
person 45 51 1031 1037 O
with 52 56 1038 1042 O
severely 57 65 1043 1051 B-chronic_disease
compromised 66 77 1052 1063 I-chronic_disease
immune 78 84 1064 1070 I-chronic_disease
system 85 91 1071 1077 I-chronic_disease
requiring 92 101 1078 1087 O
isolation 102 111 1088 1097 O

For 0 3 1098 1101 O
Flumist 4 11 1102 1109 B-treatment
participants 12 24 1110 1122 O
: 24 25 1122 1123 O
Current 26 33 1124 1131 O
illness 34 41 1132 1139 O
that 42 46 1140 1144 O
limits 47 53 1145 1151 O
delivery 54 62 1152 1160 O
to 63 65 1161 1163 O
nasal 66 71 1164 1169 O
airway 72 78 1170 1176 O

History 0 7 1177 1184 O
of 8 10 1185 1187 O
Guillain 11 19 1188 1196 B-chronic_disease
- 19 20 1196 1197 I-chronic_disease
Barre 20 25 1197 1202 I-chronic_disease
syndrome 26 34 1203 1211 I-chronic_disease

History 0 7 1212 1219 O
of 8 10 1220 1222 O
seizure 11 18 1223 1230 B-chronic_disease
disorder 19 27 1231 1239 I-chronic_disease
for 28 31 1240 1243 O
Flumist 32 39 1244 1251 O
group 40 45 1252 1257 O
participants 46 58 1258 1270 O
only 59 63 1271 1275 O

Is 0 2 1276 1278 O
pregnant 3 11 1279 1287 B-pregnancy

Male 0 4 1288 1292 B-gender

Participation 0 13 1293 1306 O
in 14 16 1307 1309 O
another 17 24 1310 1317 O
clinical 25 33 1318 1326 O
study 34 39 1327 1332 O
of 40 42 1333 1335 O
an 43 45 1336 1338 O
investigational 46 61 1339 1354 O
product 62 69 1355 1362 O
currently 70 79 1363 1372 O
or 80 82 1373 1375 O
within 83 89 1376 1382 O
the 90 93 1383 1386 O
past 94 98 1387 1391 B-upper_bound
90 99 101 1392 1394 I-upper_bound
days 102 106 1395 1399 I-upper_bound
, 106 107 1399 1400 O
or 108 110 1401 1403 O
expected 111 119 1404 1412 O
participation 120 133 1413 1426 O
during 134 140 1427 1433 O
this 141 145 1434 1438 O
study 146 151 1439 1444 O

Prior 0 5 1445 1450 O
allergic 6 14 1451 1459 O
reaction 15 23 1460 1468 O
to 24 26 1469 1471 O
commercial 27 37 1472 1482 B-allergy_name
vaccination 38 49 1483 1494 I-allergy_name

Received 0 8 1495 1503 O
the 9 12 1504 1507 O
influenza 13 22 1508 1517 B-treatment
vaccine 23 30 1518 1525 I-treatment
less 31 35 1526 1530 O
than 36 40 1531 1535 O
1 41 42 1536 1537 B-upper_bound
month 43 48 1538 1543 I-upper_bound
ago 49 52 1544 1547 O
and/or 53 59 1548 1554 O
received 60 68 1555 1563 O
the 69 72 1564 1567 O
pneumococcal 73 85 1568 1580 B-treatment
and 86 89 1581 1584 O
meningococcal 90 103 1585 1598 B-treatment
vaccine 104 111 1599 1606 I-treatment
less 112 116 1607 1611 O
than 117 121 1612 1616 O
4 122 123 1617 1618 B-upper_bound
years 124 129 1619 1624 I-upper_bound
ago 130 133 1625 1628 O

Unable 0 6 1629 1635 O
to 7 9 1636 1638 O
continue 10 18 1639 1647 O
participation 19 32 1648 1661 O
for 33 36 1662 1665 O
12 37 39 1666 1668 B-upper_bound
weeks 40 45 1669 1674 I-upper_bound

Willing 0 7 1675 1682 O
to 8 10 1683 1685 O
receive 11 18 1686 1693 O
a 19 20 1694 1695 O
single 21 27 1696 1702 O
dose 28 32 1703 1707 O
of 33 35 1708 1710 O
an 36 38 1711 1713 O
FDA 39 42 1714 1717 B-treatment
- 42 43 1717 1718 I-treatment
approved 43 51 1718 1726 I-treatment
vaccine 52 59 1727 1734 I-treatment

